Is AgelessRx Legit? We Dug Into the Company, Not Just the Longevity Claims

The short answer: yes, it's a real company — with a genuine trust gap worth knowing about

AgelessRx is a legally operating U.S. telehealth company, not a scam. It has three named, independently verifiable founders, a Chief Medical Officer with a research credential that's rare in this industry, and a Trustpilot record built on over 2,200 real reviews. That's a real foundation.

It also carries a Better Business Bureau rating of D-, including a specific mark for failing to respond to two filed complaints — a genuinely rougher picture than the glowing Trustpilot numbers suggest on their own. Both things are true at once, and a page that shows you only one of them isn't giving you the full picture.

Who's actually behind AgelessRx

AgelessRx operates under the legal entity Qalytude, Inc. (the company's original name before rebranding), headquartered in Ann Arbor, Michigan. It was co-founded by three people, most sources placing the founding in 2019:

• Anar Isman — Co-Founder and CEO, the business lead of the company.
• Dr. Sajad Zalzala, MD — Co-Founder and Chief Medical Officer. He received his medical degree from Wayne State University School of Medicine and is licensed to practice medicine in all 50 states, Washington D.C., and Ontario. Before and alongside AgelessRx, he worked as a telemedicine physician and advisor to other healthcare startups, including a stint as a telemedicine physician at Hims & Hers.
• Jonn Behrman — the third co-founder, per corporate registration records.

Named, checkable founders are a genuinely positive signal — the same signal we look for on any telehealth company, and one a fabricated or fly-by-night operation typically can't produce convincingly.

Third-party verification: what the numbers actually show

The Trustpilot vs. BBB split — the single most important thing on this page

This is the pattern worth sitting with before you decide how much weight to give either number. On Trustpilot, AgelessRx looks excellent: "Excellent" rating, consistently in the 4.4–4.5 range across more than 2,200 reviews, with the company replying warmly and specifically to both positive and negative reviews.

On the Better Business Bureau, the picture is meaningfully rougher: a D- rating, with BBB specifically noting the company failed to respond to two complaints filed against it. The complaints we reviewed cluster around a few recurring themes: subscription charges continuing after a patient believed they'd paused or canceled, slow follow-up communication after the initial intake, and occasional product quality issues — one complaint described a vial of medication leaking through its stopper and becoming unusable.

How to actually interpret two very different scores for the same company

Trustpilot reviews are submitted by customers who choose to leave one, usually shortly after an interaction — they skew toward capturing the moment-to-moment service experience. BBB complaints are filed specifically when something has gone wrong and the customer wants a formal record and resolution attempt — they skew toward capturing the worst-case experiences and how the company handled them under pressure. Both are real signals. Neither one alone is the complete picture, which is exactly why we're showing you both instead of just the one that makes for a cleaner-sounding review.

AgelessRx now offers GLP-1s too — what that means for legitimacy

AgelessRx started as a pure longevity platform — NAD+, metformin, rapamycin — but has since expanded into GLP-1 microdosing and full-dose compounded semaglutide and tirzepatide, framed around metabolic optimization rather than primary weight loss. That puts AgelessRx inside a product category that's under real, escalating federal scrutiny: the FDA has now sent three separate waves of warning letters to compounded GLP-1 marketers since September 2025 — roughly 55-80 letters in September 2025, about 30 more in March 2026, and another 25 in June 2026 — and has proposed a rule that would permanently bar large-scale compounding of semaglutide, tirzepatide, and liraglutide entirely.

We searched specifically for AgelessRx's name in FDA's public warning letter database and did not find one addressed to them, unlike DirectMeds and Hims & Hers, which we've verified directly in our other investigations. That's a genuine point in AgelessRx's favor on this specific question — but it's also worth knowing this is a fast-moving regulatory area, and the underlying compounding rule proposal affects the entire category, AgelessRx included, regardless of whether they've personally received a letter.

A general checklist: how to vet any longevity or telehealth company

This works for evaluating any company in this space, not just AgelessRx — worth bookmarking:

1. Can you find the founders by name? Real, checkable executives are a strong positive signal. "Our team of experts" with no names attached is a caution flag.
2. Does a named clinician have a real, independently verifiable credential? A specific research role (like a named clinical trial) is far more convincing than a vague "backed by science" claim.
3. What does the BBB complaint file say — not just the letter grade? Read the actual complaint themes. Billing confusion is common and often forgivable. A pattern of unresolved complaints or unresponsiveness is a bigger flag.
4. Does the company actually respond to complaints? A support team that engages and resolves issues on public record is meaningfully different from silence, even when the underlying rating isn't perfect.
5. If they sell compounded medications, what's their current regulatory standing? This space is moving fast — check for a company's name specifically in the FDA warning letter database rather than assuming an absence of news means an absence of scrutiny.

What we'd actually tell a friend

If a friend asked whether AgelessRx is safe to sign up with, the honest answer is yes — it's a real company with real, named leadership and a genuinely notable research credential behind its Chief Medical Officer. The BBB record is a real reason to go in with clear eyes about billing and communication, not a reason to assume the company is fraudulent. We'd tell them to read the cancellation and billing terms carefully before enrolling, confirm follow-up communication expectations upfront, and — if considering the GLP-1 offering specifically — treat that category with the same general caution warranted industry-wide right now, not because of anything specific to AgelessRx.

For the full breakdown of protocols, pricing, and the underlying NAD+ and rapamycin science, see our complete AgelessRx review, or our full evidence-graded look at NAD+ therapy specifically.

Frequently asked questions